Anti-diabetic activity and mechanism of action of chromium chloride

Experimental and Clinical Endocrinology and Diabetes

Volumn 112, Issue 5, 2004, Pages 248-252

  Shinde Urmila, A ^a   Sharma, G ^b   Xu Yan, J ^c   Dhalla Naranjan, S ^c   Goyal Ramesh, K ^a  

^a L M COLLEGE OF PHARMACY   (India)

^b RANBAXY RESEARCH LABORATORIES   (India)

^c ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

3T3 L1 adipocytes; C2C12 myoblasts; Chromium chloride; Insulin resistance

Indexed keywords

CARBOHYDRATE; CHROMIUM CHLORIDE; GLUCOSE; INSULIN; LIPID; STREPTOZOCIN;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CARBOHYDRATE METABOLISM; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG ACTIVITY; DRUG MECHANISM; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; IMPAIRED GLUCOSE TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESPONSE; INSULIN SENSITIVITY; LIPID METABOLISM; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; RAT; STREPTOZOCIN DIABETES;

ADIPOCYTES; ANIMALS; BLOOD GLUCOSE; CELL DIFFERENTIATION; CELL LINE; CHLORIDES; CHROMIUM COMPOUNDS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; DRINKING BEHAVIOR; ENERGY INTAKE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MICE; MUSCLE, SKELETAL; RATS; RATS, WISTAR;

EID: 2542505331     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-817971     Document Type: Article

References (27)

1. Abraham AS, Brooks BA, Eylath U. The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes. Metabolism 1992; 41: 768-771
2. Anderson RA. Chromium, glucose tolerance, diabetes and lipid metabolism. J Adv Med 1995; 8: 37-49
3. Anderson RA. Recent advances in the clinical and biochemical manifestation of chromium deficiency in human and animal nutrition. J Trace Elem Exp Med 1998; 11: 241-250
4. Anderson RA, Polansky MM, Bryden NA, Roginski EE, Mertz W, Glinsmann W. Chromium supplementation of human subjects: Effects on glucose, insulin and lipid variables. Metabolism 1983; 32: 894-899
5. Hajduch E, Rencurel F, Balendran A, Batty IH, Downes CP, Hundal HS. Serotonin (5-Hydroxytryptamine), a novel regulator of glucose transport in rat skeletal muscle. J Biol Chem 1999; 274: 13563-13568
6. Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A. Chromium deficiency, glucose intolerance and neuropathy reversed by chromium supplementation in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr 1977; 30: 531-538
7. Liu IM, Tsai CC, Lai TY, Cheng JT. Stimulatory effect of isoferulic acid on alpha 1 A - adrenoceptor to increase glucose uptake into cultured myoblasts C2C12 cell of mice. Auton Neurosci 2001; 88: 175-180
8. Lundbaek K. Intravenous glucose tolerance as a tool in definition and diagnosis of diabetes mellitus. Bri Med J 1962; 1: 1507-1513
9. Mertz W. Chromium occurrence and function in biological system. Physiol Rev 1969; 49: 163-239
10. Mertz W. Chromium in human nutrition: a review. J Nutr 1993; 123: 626-633
11. Mertz W, Roginski EE. Effect of trivalent chromium on galactose entry. J Biol Chem 1963; 238: 868-872
12. Mertz W, Roginski EE, Schwarz K. Effect of trivalent chromium complexes on glucose uptake by epididymal fat tissue of rats. J Biol Chem 1961; 236: 318-322
13. Mertz W, Toepfer EW, Roginski EE, Polansky MM. Present knowledge of role of chromium. Fed Proc 1974; 33: 2275-2280
14. Offenbacher KG, Rinko CJ, Pi-Sunyer X. The effects of inorganic chromium and brewer's yeast on glucose tolerance, plasma lipids and plasma chromium in elderly subjects. Am J Clin Nutr 1985; 42: 454-461
15. Potter JF, Levin P, Anderson RA, Freiberg JM, Andres R, Elahi D. Glucose metabolism in glucose-intolerant older people during chromium supplementation. Metabolism 1985; 34: 199-204
16. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1596-1607
17. Riales R, Albrink MJ. Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men. Am J Clin Nutr 1981; 34: 2670-2678
18. Sadur CN, Eckel RR. Insulin stimulation of adipose tissue lipoprotein lipase. Use of euglycemic clamp technique. J Clin Invest 1982; 69: 1119-1124
19. Shibata T, Matsui K, Nagao K, Shinkai H, Yonemori F, Wakitani K. Pharmacological profiles of a novel oral antidiabetic agent, JTT-, an isoxazolidinedione derivative. Euro J Pharmacol 1999; 364: 211-219
20. Shimokawa T, Kagami M, Kato M, Kurosaki E, Shibasaki M, Katoh M. Effect of YM-126,414 on glucose uptake and redistribution of glucose transporter isotype 4 in muscle cells. Euro J Pharmacol 2000; 410: 1-5
21. Shinde UA, Mehta AA, Goyal RK. Effect of chronic treatment with Bis(maltolato)oxovanadium (IV) in rat model of non-insulin-dependent-diabetes. Indian J Exp Biol 2001; 39: 864-870
22. Thomas VLK, Gropper SS. Effect of chromium nicotinic acid supplementation on selected cardiovascular risk factors. Biol Trace Elem Res 1997; 55: 297-305
23. Tuman R, Doisy R. Metabolic effects of glucose tolerance factor (GTF) in normal and genetically diabetic mice. Diabetes 1977; 26: 820-826
24. Tuman RW, Bilbo JT, Doisy RJ. Comparison and effects of natural and synthetic glucose tolerance factor in normal and genetically diabetic mice. Diabetes 1978; 27: 49-56
25. Urberg M, Zemmel MB. Evidence for synergism between chromium and nicotinic acid in the control of glucose tolerance in elderly humans. Metabolism 1987; 36: 896-899
26. Uusitupa MIJ, Mykkanen L, Siitonen O, Lakkso M, Sarlund H, Kolehmainen P, Rasanen T, Kumpulainen J, Pyorala K. Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels. Br J Nutr 1992; 68: 209-216
27. Yoshomoto S, Sakamoto K, Wakabayashi I, Masui H. Effect of chromium administration on glucose tolerance in stroke-prone spontaneously hypertensive rats with streptozotocin-induced diabetes. Metabolism 1992; 41: 636-642